These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4948086)

  • 1. Blind trial of weekly doses of sulforthomidine (fanasil (Roche)) and Disulone in lepromatous leprosy. Comparison of results after thirty months of treatment.
    Languillon J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):471-5. PubMed ID: 4948086
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical trial of sulforthomidine ('Fanasil' Roche) in lepromatous leprosy.
    Currie G
    Lepr Rev; 1966 Oct; 37(4):205-8. PubMed ID: 5341699
    [No Abstract]   [Full Text] [Related]  

  • 3. A trial of long-acting sulphonamide R.O. 4-4393 (fanasil) in treatment of cases of lepromatous leprosy with repeated E.N.L.
    Ekambaram V; Venkatachari S
    Lepr India; 1976 Jan; 48(1):24-30. PubMed ID: 1022953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses.
    Opromolla DV
    Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
    Iyer CG; Balakrishnan S; Ramu G
    Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
    Pearson JM; Pettit JH
    Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
    Waters MF; Pettit JH
    Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of a trial of dapsone vs placebo in lepromatous leprosy.
    Levy L; Murray LP
    Int J Lepr Other Mycobact Dis; 1967; 35(3):393-4. PubMed ID: 4917111
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 14. Second trial of low dosages of DDS in lepromatous leprosy.
    Leiker DL; Carling D
    Lepr Rev; 1969 Jan; 40(1):54-8. PubMed ID: 4888383
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
    Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
    Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
    [No Abstract]   [Full Text] [Related]  

  • 17. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open trial of low doses of dapsone in the management of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Rao PS
    Lepr Rev; 1969 Apr; 40(2):99-105. PubMed ID: 5792382
    [No Abstract]   [Full Text] [Related]  

  • 19. [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
    Mane I; Grauwin MY; Cartel JL
    Acta Leprol; 1995; 9(3):127-31. PubMed ID: 7631583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A report on a controlled clinical trial with conventional and one third conventional dose of dapsone administered orally once a week in lepromatous patients.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):93-7. PubMed ID: 1100971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.